Hap Trading, LLC Bluebird Bio, Inc. Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	BUY	$11.24 - $21.0 $168,779 - $315,336	15,016 Added 83.86%	32,921 $629,000
Q2 2021 Aug 11, 2021	BUY	$18.04 - $22.09 $61,931 - $75,834	3,433 Added 23.72%	17,905 $573,000
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $36,249 - $74,049	-2,185 Reduced 13.12%	14,472 $436,000
Q2 2020 Aug 10, 2020	BUY	$27.12 - $45.97 $171,262 - $290,300	6,315 Added 61.06%	16,657 $1.02 Million
Q1 2020 May 08, 2020	SELL	$26.16 - $63.5 $220,790 - $535,940	-8,440 Reduced 44.94%	10,342 $475,000
Q4 2019 Feb 11, 2020	BUY	$46.96 - $61.67 $882,002 - $1.16 Million	18,782 New	18,782 $1.65 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.